Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/12/24 16:21 | 6/10/24 | INSM | Health | Drug | Pharmaceutical Preparations | Flammer Martina M.D. | NJ | O | Chief Me | 4 | S.dm | -7,976 | 49.39 | 0 | -161 | 111 | D | |||||||||||||||
6/5/24 16:23 | 6/3/24 | INSM | Health | Drug | Pharmaceutical Preparations | Schaeffer Orlov S Nicole | NJ | O | Chief Pe | 3 | S.d | -4,571 | 51.36 | 0 | -89 | 109 | D | |||||||||||||||
5/30/24 17:46 | 5/28/24 | INSM | Health | Drug | Pharmaceutical Preparations | Wise John Drayton | NJ | O | Chief Co | 2 | S.d | -521 | 40.22 | 0 | -13 | 123 | D | |||||||||||||||
5/30/24 17:45 | 5/28/24 | INSM | Health | Drug | Pharmaceutical Preparations | Smith Michael Alexander | NJ | O | GC | 2 | S.d | -2,344 | 47.06 | 0 | -50 | 95 | D | |||||||||||||||
5/30/24 17:41 | 5/28/24 | INSM | Health | Drug | Pharmaceutical Preparations | Bonstein Sara | NJ | O | CFO | 2 | S.dm | -12,345 | 48.92 | 0 | -252 | 117 | D | |||||||||||||||
5/17/24 16:15 | 5/17/24 | INSM | Health | Drug | Pharmaceutical Preparations | Adsett Roger | NJ | O | COO | 2 | S.d | -350 | 25.32 | 0 | -14 | 155 | D | |||||||||||||||
5/15/24 16:34 | 5/14/24 | INSM | Health | Drug | Pharmaceutical Preparations | Lewis William | NJ | DO | Chair,CE | 1 | S.d | -566 | 25.52 | 0 | -22 | 669 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |